Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Glimepiride (4mg) + Metformin (1000mg) SR Bilayered Smart Tablet
Therapeutic Category
Antidiabetic, Diabetic, Endocrinology
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹224/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Gimtype M4 Forte is a bilayered smart tablet specifically formulated for the effective management of type 2 diabetes mellitus. This advanced formulation combines two powerful active ingredients: Glimepiride (4 mg) and Metformin (1000 mg) sustained release (SR). Together, these components provide a comprehensive approach to controlling blood glucose levels, making it an essential option for patients with diabetes. Glimepiride, a member of the sulfonylurea class, works by stimulating the pancreas to produce more insulin, which is crucial for lowering blood sugar levels. This action is particularly effective in managing postprandial glucose levels. Metformin, on the other hand, is a biguanide that enhances insulin sensitivity in peripheral tissues and reduces hepatic glucose production. The sustained release formulation of Metformin ensures a gradual release of the medication, helping to maintain stable blood glucose levels throughout the day while minimizing gastrointestinal side effects. The combination of Glimepiride and Metformin in Gimtype M4 Forte not only aids in achieving better glycemic control but also helps in reducing the risk of diabetes-related complications. This dual-action approach is especially beneficial for patients who may not achieve adequate control with Metformin alone. By addressing multiple mechanisms involved in glucose regulation, Gimtype M4 Forte provides a more effective solution for managing type 2 diabetes.
Gimtype M4 Forte is a bilayered smart tablet specifically formulated for the effective management of type 2 diabetes mellitus. This advanced formulation combines two powerful active ingredients: Glimepiride (4 mg) and Metformin (1000 mg) sustained release (SR). Together, these components provide a comprehensive approach to controlling blood glucose levels, making it an essential option for patients with diabetes.
Glimepiride, a member of the sulfonylurea class, works by stimulating the pancreas to produce more insulin, which is crucial for lowering blood sugar levels. This action is particularly effective in managing postprandial glucose levels. Metformin, on the other hand, is a biguanide that enhances insulin sensitivity in peripheral tissues and reduces hepatic glucose production. The sustained release formulation of Metformin ensures a gradual release of the medication, helping to maintain stable blood glucose levels throughout the day while minimizing gastrointestinal side effects.
The combination of Glimepiride and Metformin in Gimtype M4 Forte not only aids in achieving better glycemic control but also helps in reducing the risk of diabetes-related complications. This dual-action approach is especially beneficial for patients who may not achieve adequate control with Metformin alone. By addressing multiple mechanisms involved in glucose regulation, Gimtype M4 Forte provides a more effective solution for managing type 2 diabetes.
Common side effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort. Hypoglycemia is also a risk, especially if meals are missed or if there is increased physical activity.
Gimtype M4 Forte is indicated for the management of type 2 diabetes mellitus, particularly in conjunction with diet and exercise
Consult your healthcare provider before starting this medication, especially if you have a history of kidney or liver disease.
Store Gimtype M4 Forte tablets in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.
Composition : Glibenclamide I.P. 5mg + Metformin Hydrochloride I.P. 500mg + Pioglitazone Hydrochloride I.P. 15mg Tablets
Composition : Glimepiride (1mg) Tablet
Composition : Glimepiride (2mg) Tablet
Composition : Glimepiride 1mg + Metformin 500mg + Pioglitazone 15mg Bi-Layered Tablets
Composition : Glimepiride 2mg + Metformin Hydrochloride I.P. 500mg + Pioglitazone 15mg Bi-Layered Tablets
Composition : Gliclazide 80mg + Metformin Hydrochloride I.P. 500mg Tablets
Composition : LISINOPRIL 5 + AMLODIPINE 5 MG tablet
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Aspirin 75 mg + Rosuvastatin 20 mg + Clopidogrel 75 mg capsule
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This anti-diabetic combination is widely used in type 2 diabetes management, making it a strong prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in type 2 diabetes, fasting and post-meal blood sugar control, insulin resistance, and long-term glycemic management. It is commonly prescribed by physicians and diabetologists for patients requiring higher-dose dual therapy with sustained-release Metformin for better compliance.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Glimepiride 4mg + Metformin 1000mg SR Bilayered Smart Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from strong chronic prescription demand, lifelong therapy usage, and steady monthly repeat sales in diabetes care when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this diabetic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.